↓ Skip to main content

Adjuvant treatment of anaplastic oligodendrogliomas and oligoastrocytomas

Overview of attention for article published in Cochrane database of systematic reviews, May 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
60 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Adjuvant treatment of anaplastic oligodendrogliomas and oligoastrocytomas
Published in
Cochrane database of systematic reviews, May 2014
DOI 10.1002/14651858.cd007104.pub2
Pubmed ID
Authors

Magali Lecavalier-Barsoum, Harvey Quon, Bassam Abdulkarim

Abstract

Standard care of adjuvant treatment for anaplastic oligodendrogliomas (AO) and anaplastic oligoastrocytomas (AOA) is not yet well defined. The benefit of adjuvant chemotherapy and radiotherapy (RT), given as single modalities or sequentially, is still unclear. Furthermore, insight into the predictive and prognostic impact of various biomarkers is surging.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 60 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 60 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 11 18%
Researcher 9 15%
Unspecified 8 13%
Student > Master 7 12%
Student > Bachelor 5 8%
Other 20 33%
Readers by discipline Count As %
Medicine and Dentistry 32 53%
Unspecified 10 17%
Nursing and Health Professions 4 7%
Agricultural and Biological Sciences 3 5%
Neuroscience 3 5%
Other 8 13%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 June 2014.
All research outputs
#9,618,890
of 12,527,219 outputs
Outputs from Cochrane database of systematic reviews
#8,470
of 8,923 outputs
Outputs of similar age
#117,435
of 188,489 outputs
Outputs of similar age from Cochrane database of systematic reviews
#172
of 189 outputs
Altmetric has tracked 12,527,219 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one is in the 10th percentile – i.e., 10% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 188,489 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 32nd percentile – i.e., 32% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 189 others from the same source and published within six weeks on either side of this one. This one is in the 5th percentile – i.e., 5% of its contemporaries scored the same or lower than it.